Cargando…

Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis

Whether Nucleos(t)ide analogs(NA) treatment can delay the onset of HCC remains unclear. We retrospectively analyzed the clinical data of patients with HBV-related cirrhosis and HCC from 2000 to 2012. Cox proportional hazards model was used to explore the association between NA treatment and postpone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Jingfeng, Zhang, Zheng, Qin, Enqiang, Hou, Jun, Liu, Shuiwen, Liu, Zengmin, Li, Shuo, Wei, Zhenman, Zhong, Yanwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722517/ https://www.ncbi.nlm.nih.gov/pubmed/29228565 http://dx.doi.org/10.18632/oncotarget.18075

Ejemplares similares

Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B
por: Bi, Jingfeng, et al.
Publicado: (2017)

Preclinical and clinical development of the anti-HIV, anti-HBV oxathiolane nucleoside analog emtricitabine
por: Painter, George R., et al.
Publicado: (2003)

Antiviral nucleoside analogs
por: Kataev, Vladimir E., et al.
Publicado: (2021)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Nucleoside Analogs with Fleximer Nucleobase
por: Chudinov, Mikhail V.
Publicado: (2020)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
por: Yang, Dan-Hong, et al.
Publicado: (2021)

Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)

Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants
por: Thompson, Alexander J., et al.
Publicado: (2023)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

New insights into the synergism of nucleoside analogs with radiotherapy
por: Lee, Michael W, et al.
Publicado: (2013)

Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication
por: Barral, Karine, et al.
Publicado: (2011)

Successful Nucleoside Analog and Corticosteroid Therapy for Chronic Inflammatory Demyelinating Polyneuropathy in a Patient With Hepatitis B Virus Liver Cirrhosis
por: Nugraha, Eka Surya, et al.
Publicado: (2021)

Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection
por: Xie, Yangxin, et al.
Publicado: (2017)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
por: Borbone, Nicola, et al.
Publicado: (2021)

Efficient Synthesis of Purine Nucleoside Analogs by a New Trimeric Purine Nucleoside Phosphorylase from Aneurinibacillus migulanus AM007
por: Liu, Gaofei, et al.
Publicado: (2019)

Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
por: Nam, Joon Yeul, et al.
Publicado: (2020)

Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis
por: Xie, Yangxin, et al.
Publicado: (2017)

Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy
por: NISHIKAWA, HIROKI, et al.
Publicado: (2013)

Profile of HBV Integration in the Plasma DNA of Hepatocellular Carcinoma Patients
por: Li, Weiyang, et al.
Publicado: (2019)

Studies on the correlation between mutation and integration of HBV in hepatocellular carcinoma
por: Cui, Xiaofang, et al.
Publicado: (2020)

Diverse models for anti-HIV activity of purine nucleoside analogs
por: Khatri, Naveen, et al.
Publicado: (2015)

The nucleoside analog clitocine is a potent and efficacious readthrough agent
por: Friesen, Westley J., et al.
Publicado: (2017)

Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
por: Gmeiner, William H.
Publicado: (2019)

Synthesis of Sugar and Nucleoside Analogs and Evaluation of Their Anticancer and Analgesic Potentials
por: Hussain, Fahad, et al.
Publicado: (2022)

Nucleoside Analogs: A Review of Its Source and Separation Processes
por: Wang, Pan, et al.
Publicado: (2023)

Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes
por: Tu, Bo, et al.
Publicado: (2017)

Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas
por: Wei, Yanyan, et al.
Publicado: (2019)

Directed evolution of an orthogonal nucleoside analog kinase via fluorescence-activated cell sorting
por: Liu, Lingfeng, et al.
Publicado: (2009)

Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma
por: Yin, Jia Wen, et al.
Publicado: (2016)

Identification of Structural and Molecular Features Involved in the Transport of 3′-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
por: Rahman, MD Fazlur, et al.
Publicado: (2018)

Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: He, Lingling, et al.
Publicado: (2017)

Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in Borrelia burgdorferi
por: Chakraborti, Monideep, et al.
Publicado: (2020)

Structural Insights Into Tautomeric Dynamics in Nucleic Acids and in Antiviral Nucleoside Analogs
por: Fedeles, Bogdan I., et al.
Publicado: (2022)

Nucleoside analogs in ADAR guide strands targeting 5′-UA̲ sites
por: Brinkman, Hannah F., et al.
Publicado: (2022)

Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus
por: Dittmar, Mark, et al.
Publicado: (2023)

Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related Cirrhosis
por: Lin, Dong, et al.
Publicado: (2013)

Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
por: Lee, Junggyu, et al.
Publicado: (2015)

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
por: Zhu, Dong-Mei, et al.
Publicado: (2020)

Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis
por: Li, Yaqun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_osan24nrbsd5kur4hdo8u0smd3